Develops a gelatin-based hydrogel that promotes wound repair in diabetic models, suggesting its potential for tissue regeneration.
Effective chronic skin wound healing remains challenging due to excessive inflammation, insufficient vascular support, and impaired extracellular matrix remodeling. By rationally designing and integrating complementary biomaterials, it is possible to synergistically tailor physicochemical properties and biological performance for tissue repair and regeneration. In this study, a gelatin-based composite hydrogel incorporating recombinant type III collagen (rColIII) and carboxymethyl cellulose (CMC) was developed via EDC/NHS-mediated crosslinking and evaluated for wound repair. By tuning the rColIII/CMC ratio, the hydrogel mechanical modulus (G′) increased from ~1.2 kPa to ~2.6 kPa, and enzymatic degradation could be modulated, as reflected by changes in the remaining material mass. The optimized Gel/rCol/CMC-1 formulation supported 3T3 cell migration (1.8-fold increase at 24 h) and promoted a pro-regenerative (M2-like) macrophage phenotype in vitro. In a full-thickness diabetic wound model, Gel/rCol/CMC-1 accelerated wound closure (82.3 ± 4.7% vs. 56.9 ± 5.1% at day 14) and enhanced tissue quality, evidenced by more organized collagen deposition and increased CD31+/α-SMA+ vessel density. These results demonstrate that formulation-driven tuning of gelatin/rColIII/CMC matrices creates a supportive microenvironment for coordinated wound repair, highlighting their potential as regenerative hydrogel dressings for difficult-to-heal wounds.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: